Erratum: Eriocitrin and apigenin as new carbonic anhydrase va inhibitors from a virtual screening of calabrian natural products (Planta Medica (2015) 81:6 (533-540) DOI: 10.1055/s-0034-1396139);Eriocitrin and apigenin as new carbonic anhydrase VA inhibitors from a virtual screening of calabrian natural products

Planta Medica

Volumn 81, Issue 6, 2015, Pages 533-540

  Gidaro, Maria Concetta ^a   Alcaro, Francesca ^a   Carradori, Simone ^b   Costa, Giosuè ^a   Vullo, Daniela ^c   Supuran, Claudiu T ^c   Alcaro, Stefano ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Allium cepa var. Tropea; Citrus bergamia; docking; flavonoids; human carbonic anhydrase inhibition; Liliaceae; Rutaceae; structure based virtual screening

Indexed keywords

APIGENIN; CARBONATE DEHYDRATASE INHIBITOR; ERIOCITRIN; NATURAL PRODUCT; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; FLAVANONE DERIVATIVE;

ARTICLE; BIOLOGICAL ACTIVITY; CITRUS; CONTROLLED STUDY; DRUG SCREENING; IN VITRO STUDY; NONHUMAN; ONION; ALLIUM; CHEMISTRY; ISOLATION AND PURIFICATION;

ALLIUM ATRORUBENS; ALLIUM CEPA; CITRUS AURANTIUM BERGAMIA; LILIACEAE; RUTACEAE;

ALLIUM; APIGENIN; BIOLOGICAL PRODUCTS; CARBONIC ANHYDRASE INHIBITORS; CITRUS; FLAVANONES;

EID: 84928810399     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1396263     Document Type: Erratum

References (49)

1. Newman D. J., Cragg G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod: 2012; 75 311 335
2. Langer T., Hoffmann R. D. Virtual screening: an effective tool for lead structure discovery? Curr Pharm Des: 2001; 7 509 527
3. Artese A., Alcaro S., Moraca F., Reina R., Ventura M., Costantino G., Beccari A. R., Ortuso F. State-of-the-art and dissemination of computational tools for drug-design purposes: a survey among Italian academics and industrial institutions. Future Med Chem: 2013; 5 907 927
4. Lavecchia A., Di Giovanni C. Virtual screening strategies in drug discovery: a critical review. Current Med Chem: 2013; 20 2839 2860
5. Alcaro S., Musetti C., Distinto S., Casatti M., Zagotto G., Artese A., Parrotta L., Moraca F., Costa G., Ortuso F., Maccioni E., Sissi C. Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure based virtual screening approaches. J Med Chem: 2013; 56 843 855
6. Artese A., Costa G., Ortuso F., Parrotta L., Alcaro S. Identification of new natural DNA G-quadruplex binders selected by a structure-based virtual screening approach. Molecules: 2013; 18 12051 12070
7. Statti G. A., Conforti F., Sacchetti G., Muzzoli M., Agrimonti C., Menichini F. Chemical and biological diversity of Bergamot (Citrus bergamia) in relation to environmental factors. Fitoterapia: 2004; 75 212 216
8. Furia E., Naccarato A., Sindona G., Stabile G., Tagarelli A. Multielement fingerprinting as a tool in origin authentication of PGI food products: Tropea red onion. J Agric Food Chem: 2011; 59 8450 8457
9. Gennaro L., Leonardi C., Esposito F., Salucci N., Maiani G., Quaglia G., Fogliano V. Flavonoid and carbohydrate contents in Tropea red onions: effects of homelike peeling and storage. J Agric Food Chem: 2002; 50 1904 1910
10. Dorant E., Van den Brandt P. A., Goldbohm R. A., Sturmans F. Consumption of onions and a reduced risk of stomach carcinoma. Gastroenterology: 1996; 110 12
11. Suh H. J., Lee J. M., Cho J. S., Kim Y. S., Chung S. H. Radical scavenging compounds in onion skin. Food Res Int: 1999; 32 659
12. Pernice R., Borriello G., Ferracane R., Borrelli R. C., Cennamo F., Ritieni A. Bergamot: A source of natural antioxidants for functionalized fruit juices. Food Chem: 2009; 112 545 550
13. Tripoli E., La Guardia M., Giammanco S., Di Majo D., Giammanco M. Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review. Food Chem: 2007; 104 466 479
14. Mollace V., Sacco I., Janda E., Malara C., Ventrice D., Colica C., Visalli V., Muscoli S., Ragusa S., Muscoli C., Rotiroti D., Romeo F. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia: 2007; 82 309 316
15. Supuran C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov: 2008; 7 168 181
16. Supuran C. T., Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem: 2007; 15 4336 4350
17. Pastorekova S., Parkkila S., Pastorek J., Supuran C. T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enz Inhib Med Chem: 2004; 19 199 229
18. Supuran C. T., Scozzafava A., Conway J. Carbonic anhydrases: catalytic mechanisms, distribution and physiological roles. In: Supuran C. T., Scozzafava A., Conway J. editors Carbonic anhydrase: its inhibitors and activators. Boca Raton CRC Press: 2004; 1 24
19. Supuran C. T. Carbonic anhydrases as drug targets-an overview. Curr Top Med Chem: 2007; 7 825 833
20. Aggarwal M., Kondeti B., McKenna R. Insights towards sulfonamide drug specificity in α -carbonic anhydrases. Bioorg Med Chem: 2013; 21 1526 1533
21. Alterio V., Fiore A. D., DAmbrosio K., Supuran C. T., Simone G. D. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev: 2012; 112 4421 4468
22. Gieling R. G., Williams K. J. Carbonic anhydrase IX as a target for metastatic disease. Biorg Med Chem: 2013; 21 1470 1476
23. Ekinci D., Karagoz L., Ekinci D., Senturk M., Supuran C. T. Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. J Enz Inhib Med Chem: 2013; 28 283 288
24. Koz Ö, Ekinci D., Perrone A., Piacente S., Alanku͆-Çall͆kan Ö, Bedir E., Supuran C. T. Analysis of saponins and phenolic compounds as inhibitors of α -carbonic anhydrase isoenzymes. J Enz Inhib Med Chem: 2013; 28 412 417
25. Berman H. M., Westbrook J., Feng Z., Gilliland G., Bhat T. N., Weissig H., Shindyalov I. N., Bourne P. E. The Protein Data Bank. Nucleic Acids Res: 2000; 28 235 242
26. Ma D. L., Chana D. SH, Leung C. H. Molecular docking for virtual screening of natural product databases. Chem Sci: 2011; 2 1656
27. Software: MacroModel, version 10.3. New York Schrödinger, LLC: 2014
28. Software: PyMOL Molecular Graphics System, Version 1.7.0.0. New York Schrödinger, LLC: 2014
29. Shah G. N., Hewett-Emmett D., Grubb J. H., Migas M. C., Fleming R. E., Waheed A., Sly W. S. Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles. PNAS: 2000; 97 1677 1682
30. De Simone G., Supuran C. T. Antiobesity carbonic anhydrase inhibitors. Curr Top Med Chem: 2007; 7 879 884
31. Poulsen S. A., Wilkinson B. L., Innocenti A., Vullo D., Supuran C. T. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives. Bioorg Med Chem Lett: 2008; 18 4624 4627
32. DAscenzio M., Carradori S., De Monte C., Secci D., Ceruso M., Supuran C. T. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII. Bioorg Med Chem: 2014; 22 1821 1831
33. Kim J. P., Lee I., Seo J., Jung M., Kim Y., Yim N., Bae K. Vitexin, orientin and other flavonoids from Spirodela polyrhiza inhibit adipogenesis in 3T3-L1 cells. Phytother Res: 2010; 24 1543 1548
34. Hiramitsu M., Shimada Y., Kuroyanagi J., Inoue T., Katagiri T., Zang L., Nishimura Y., Nishimura N., Tanaka T. Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. Sci Rep: 2014; 4 3708
35. PUBCHEM free web site. Available at. http://pubchem.ncbi.nlm.nih.gov Acessed January 10, 2014
36. Software: Maestro, version 9.7. New York Schrödinger, LLC: 2014
37. Software: LigPrep, version 2.9. New York Schrödinger, LLC: 2014
38. Kirchmair J., Laggner C., Wolber G., Langer T. Comparative analysis of protein-bound ligand conformations with respect to catalysts conformational space subsampling algorithms. J Chem Inf Model: 2005; 45 422 430
39. Congreve M., Murray C. W., Blundell T. L. Structural biology and drug discovery. Drug Disc Today: 2005; 10 895 907
40. Chakravarty S., Kannan K. K. Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme. J Mol Biol: 1994; 243 298 309
41. Moeker J., Peat T. S., Bornaghi L. F., Vullo D., Supuran C. T., Poulsen S. A. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes. J Med Chem: 2014; 57 3522 3531
42. Boriack-Sjodin P. A., Heck R. W., Laipis P. J., Silverman D. N., Christianson D. W. Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-A resolution: implications for catalytic proton transfer and inhibitor design. Proc Natl Acad Sci U S A: 1995; 92 10949 10953
43. Alterio V., Hilvo M., Di Fiore A., Supuran C. T. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci U S A: 2009; 106 16233 16238
44. Dudutiene V., Zubriene A., Smirnov A., Gylyte J., Timm D., Manakova E., GraŽulis S., Matulis D. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Bioorg Med Chem: 2013; 21 2093 2106
45. Software: Schrödinger Suite 2013 Protein Preparation Wizard; Epik version 2.7. New York: Schrödinger, LLC; 2013; Impact version 6.2. New York: Schrödinger, LLC; 2013; Prime version 3.4. New York Schrödinger, LLC: 2014
46. Software: Glide, version 6.2. New York Schrödinger, LLC: 2014
47. Khalifah R. G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem: 1971; 246 2561 2573
48. Lopez M., Drillaud N., Bornaghi L. F., Poulsen S. A. Synthesis of S-glycosyl primary sulfonamides. J Org Chem: 2009; 74 2811 2816
49. 50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations. J Pharmacol Toxicol Methods: 2001; 46 61 71